Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Histologic Type × Chemoradiotherapy × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Carcinoma, Squamous Cell 3 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Tonsillar Neoplasms 1 Resectable Esophageal Cancer 1 Pharyngeal Neoplasms 1 Neoplasms by Site 1 Neoplasms 1 Muscle Invasive Bladder Cancer 1 Melanoma 1 Limited Stage Small Cell Lung Cancer 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Adenosquamous 1 Brain Neoplasms 1 Adenocarcinoma 1

Interventions

ponatinib 4 Rituximab 3 Gemcitabine 3 130-nm albumin-bound paclitaxel 3 pralsetinib 2 pembrolizumab 2 napabucasin 2 Vincristine 2 Prednisone 2 Irinotecan 2 Imatinib Mesylate 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Carboplatin 2 Brentuximab Vedotin 2 tetulomab tetraxetan lu-177 1 pamiparib 1 nirogacestat 1 nilotinib 1 ibritumomab tiuxetan 1 bosutinib 1 blinatumomab 1 Vorinostat 1 Temozolomide 1 Radiation 1 Pemetrexed 1 Papanicolaou Test 1 Paclitaxel 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡